Spermatocytic tumor (ST) is a rare type of germ cell tumor that occurs exclusively in the postpubertal testis and typically affects elderly men. Most STs are benign, but rare cases exhibit aggressive clinical behavior, often in association with transition to sarcomatoid histology. Limited molecular analyses have been performed on STs; therefore, their genomic and epigenomic features remain incompletely described. Twenty-seven samples from 25 individual patients were analyzed with a combination of DNA sequencing panels, genomic methylation profiling, SNP array, isochromosome (12p) [i(12p)] FISH, and immunohistochemistry. The series included five metastasizing tumors (three with sarcomatoid transformation, one anaplastic, and one conventional) and 20 non-metastasizing tumors (14 anaplastic and six conventional). Anaplastic tumors comprised a monomorphic population of intermediate-sized neoplastic cells, as previously described. Multiomic analyses demonstrated that there were two genomic subgroups of STs: one with diploid genomes and hotspot RAS/RAF variants and the other with global ploidy shift and absence of recurrent mutations. Relative gain of chromosome 9 was a consistent finding in both subgroups. A comparison of metastasizing and non-metastasizing cases demonstrated that aggressive behavior was associated with the acquisition of pathogenic TP53 mutations and/or relative gains of 12p/i(12p). In cases with sarcomatoid transformation, TP53 mutations seem to underlie the transition to sarcomatoid histology. Genomic methylation analysis demonstrated that aggressive cases with gains of 12p cluster closer to pure seminomas than to STs without gains of 12p. In conclusion, STs include two genomic subgroups, characterized by global ploidy shifts without recurrent mutations and diploid genomes with RAS/RAF hotspot mutations, respectively. Biologic progression was associated with relative gains of 12p and TP53 mutations. The findings in STs with relative gains of 12p suggest that they may exhibit biologic characteristics akin to those seen in germ cell neoplasia in situ-related germ cell tumors rather than non-germ cell neoplasia in situ-derived STs. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Centre for Cancer Biomarkers and Biotherapeutics Barts Cancer Institute Queen Mary University of London London UK

Department of Medical and Surgical Sciences University of Bologna Bologna Italy

Department of Pathology Brigham and Women's Hospital Harvard Medical School Boston MA USA

Department of Pathology Charles University Plzen Czech Republic

Department of Pathology Douglass Hanly Moir Pathology Macquarie University Sydney NSW Australia

Department of Pathology Emory University School of Medicine Atlanta GA USA

Department of Pathology Indiana University Indianapolis IN USA

Department of Pathology Instituto Português de Oncologia Lisbon Portugal

Department of Pathology Massachusetts General Hospital Harvard Medical School Boston MA USA

Department of Pathology Mayo Clinic Rochester MN USA

Department of Pathology New York University New York NY USA

Department of Pathology Universita Vita Salute San Raffaele Milan Italy

Department of Pathology Vanderbilt University Nashville TN USA

Pathology Unit Maggiore Hospital AUSL Bologna Bologna Italy

Zobrazit více v PubMed

Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer 2019; 19: 522-537.

Giannoulatou E, Maher GJ, Ding Z, et al. Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline. PLoS One 2017; 12: e0178169.

Grogg JB, Schneider K, Bode P-K, et al. A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis. J Cancer Res Clin Oncol 2019; 145: 3037-3045.

Mikuz G, Böhm GW, Behrend M, et al. Therapy-resistant metastasizing anaplastic spermatocytic seminoma: a cytogenetic hybrid: a case report. Anal Quant Cytopathol Histopathol 2014; 36: 177-182.

Gupta S, Farooq A, Rowsey RA, et al. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants. Hum Pathol 2022; 124: 85-95.

Hu R, Ulbright TM, Young RH. Spermatocytic seminoma: a report of 85 cases emphasizing its morphologic spectrum including some aspects not widely known. Am J Surg Pathol 2019; 43: 1-11.

Stueck AE, Grantmyre JE, Wood LA, et al. Spermatocytic tumor with sarcoma: a rare testicular neoplasm. Int J Surg Pathol 2017; 25: 559-562.

Dias AF, Dvindenko E, Santos F, et al. Sarcomatoid spermatocytic tumour: report of a rare case and literature review. Int J Surg Pathol 2023; 31: 728-733.

Wagner T, Grantham M, Berney D. Metastatic spermatocytic tumour with hybrid genetics: breaking the rules in germ cell tumours. Pathology 2018; 50: 562-565.

Garcia EP, Minkovsky A, Jia Y, et al. Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer. Arch Pathol Lab Med 2017; 141: 751-758.

Sholl LM, Do K, Shivdasani P, et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight 2016; 1: e87062.

Abo RP, Ducar M, Garcia EP, et al. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic Acids Res 2015; 43: e19.

Papke DJ, Nowak JA, Yurgelun MB, et al. Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma. Mod Pathol 2018; 31: 1882-1890.

Christakis AG, Papke DJ, Nowak JA, et al. Targeted cancer next-generation sequencing as a primary screening tool for microsatellite instability and lynch syndrome in upper gastrointestinal tract cancers. Cancer Epidemiol Biomarkers Prev 2019; 28: 1246-1251.

McCarthy MR, Nichols PE, Sharma V, et al. Molecular and immunophenotypic correlates of metastatic epithelioid angiomyolipoma include alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med 2023; 147: 817-825.

Gupta S, Erickson LA, Lohse CM, et al. Assessment of risk of hereditary predisposition in patients with melanoma and/or mesothelioma and renal neoplasia. JAMA Netw Open 2021; 4: e2132615.

Wang Y, Cottman M, Schiffman JD. Molecular inversion probes: a novel microarray technology and its application in cancer research. Cancer Genet 2012; 205: 341-355.

Freitag CE, Sukov WR, Bryce AH, et al. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. Hum Pathol 2021; 112: 20-34.

Gupta S, Sukov WR, Vanderbilt CM, et al. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urol Oncol 2022; 40: 512-524.

Serrano J, Snuderl M. Whole genome DNA methylation analysis of human glioblastoma using Illumina BeadArrays. Methods Mol Biol 2018; 1741: 31-51.

Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014; 30: 1363-1369.

Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 2016; 32: 2847-2849.

Maher GJ, Goriely A, Wilkie AOM. Cellular evidence for selfish spermatogonial selection in aged human testes. Andrology 2014; 2: 304-314.

Rahbari R, Wuster A, Lindsay SJ, et al. Timing, rates and spectra of human germline mutation. Nat Genet 2016; 48: 126-133.

Rosenberg C, Mostert MC, Schut TB, et al. Chromosomal constitution of human spermatocytic seminomas: comparative genomic hybridization supported by conventional and interphase cytogenetics. Genes Chromosomes Cancer 1998; 23: 286-291.

Looijenga LHJ, Hersmus R, Gillis AJM, et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 2006; 66: 290-302.

Verdorfer I, Rogatsch H, Tzankov A, et al. Molecular cytogenetic analysis of human spermatocytic seminomas. J Pathol 2004; 204: 277-281.

Zhang T, Oatley J, Bardwell VJ, et al. DMRT1 is required for mouse spermatogonial stem cell maintenance and replenishment. PLoS Genet 2016; 12: e1006293.

Matson CK, Murphy MW, Griswold MD, et al. The mammalian doublesex homolog DMRT1 is a transcriptional gatekeeper that controls the mitosis versus meiosis decision in male germ cells. Dev Cell 2010; 19: 612-624.

Rijlaarsdam MA, Tax DMJ, Gillis AJM, et al. Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors. PLoS One 2015; 10: e0122146.

Kristensen DG, Mlynarska O, Nielsen JE, et al. Heterogeneity of chromatin modifications in testicular spermatocytic seminoma point toward an epigenetically unstable phenotype. Cancer Genet 2012; 205: 425-431.

FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity